 | • レポートコード：MRC2304L205 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、253ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、世界のタンパク質精製＆分離市場規模が2021年に7,121.35百万ドル、2022年に8,189.17百万ドルとなり、その後2027年までにCAGR 15.17％で成長して16,620.11百万ドルに達すると予測しています。当書は、タンパク質精製＆分離の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（消耗品、機器）、技術別分析（クロマトグラフィー、電気泳動、沈殿、限外ろ過、ウェスタンブロッティング）、用途別分析（バイオマーカー発見、診断、薬物スクリーニング、タンパク質間相互作用研究）、エンドユーザー別分析（学術研究機関、CRO、病院、製薬会社＆バイオテクノロジー会社）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。また、当書には、Abcam PLC、Agilent Technologies、BioAstrum Corporation、BioVision, Inc.、Creative Biostructure、Eurofins DiscoverX Products、Expedeon Ltd.、GEA Group Aktiengesellschaft、General Electric Company、Geno Technology Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のタンパク質精製＆分離市場規模：製品別 - 消耗品の市場規模 - 機器の市場規模 ・世界のタンパク質精製＆分離市場規模：技術別 - クロマトグラフィーの市場規模 - 電気泳動の市場規模 - 沈殿の市場規模 - 限外ろ過の市場規模 - ウェスタンブロッティングの市場規模 ・世界のタンパク質精製＆分離市場規模：用途別 - バイオマーカー発見における市場規模 - 診断における市場規模 - 薬物スクリーニングにおける市場規模 - タンパク質間相互作用研究における市場規模 ・世界のタンパク質精製＆分離市場規模：エンドユーザー別 - 学術研究機関における市場規模 - CROにおける市場規模 - 病院における市場規模 - 製薬会社＆バイオテクノロジー会社における市場規模 ・世界のタンパク質精製＆分離市場規模：地域別 - 南北アメリカのタンパク質精製＆分離市場規模 アメリカのタンパク質精製＆分離市場規模 カナダのタンパク質精製＆分離市場規模 ブラジルのタンパク質精製＆分離市場規模 ... - アジア太平洋のタンパク質精製＆分離市場規模 日本のタンパク質精製＆分離市場規模 中国のタンパク質精製＆分離市場規模 インドのタンパク質精製＆分離市場規模 韓国のタンパク質精製＆分離市場規模 台湾のタンパク質精製＆分離市場規模 ... - ヨーロッパ/中東/アフリカのタンパク質精製＆分離市場規模 イギリスのタンパク質精製＆分離市場規模 ドイツのタンパク質精製＆分離市場規模 フランスのタンパク質精製＆分離市場規模 ロシアのタンパク質精製＆分離市場規模 ... - その他地域のタンパク質精製＆分離市場規模 ・競争状況 ・企業情報 |
The Global Protein Purification & Isolation Market size was estimated at USD 7,121.35 million in 2021 and expected to reach USD 8,189.17 million in 2022, and is projected to grow at a CAGR 15.17% to reach USD 16,620.11 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Protein Purification & Isolation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Instruments. The Consumables is further studied across Columns, Kits, Magnetic beads, Reagents, and Resins.
Based on Technology, the market was studied across Chromatography, Electrophoresis, Precipitation, Ultrafiltration, and Western blotting. The Chromatography is further studied across Affinity chromatography, Hydrophobic interaction chromatography, Ion exchange chromatography, Reversed phase chromatography, and Size exclusion chromatography. The Electrophoresis is further studied across Capillary electrophoresis, Gel electrophoresis, and Isoelectric focusing.
Based on Application, the market was studied across Biomarker discovery, Diagnostics, Drug screening, and Protein-protein interaction studies.
Based on End-user, the market was studied across Academic and research institutes, CROs, Hospitals, and Pharmaceutical and biotechnological companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Protein Purification & Isolation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Purification & Isolation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Purification & Isolation Market, including Abcam PLC, Agilent Technologies, BioAstrum Corporation, BioVision, Inc., Creative Biostructure, Eurofins DiscoverX Products, Expedeon Ltd., GEA Group Aktiengesellschaft, General Electric Company, Geno Technology Inc., Jiangsu kaimi membrane technology Co.,Ltd., Labome, Merck KGaA, Norgen Biotek Corp., OPRL Biosciences Pvt.,Ltd., Promega Corporation, Purolite, Qiagen N.V, Roche Applied Science, Sigma-Aldrich Co., Synder Filtration, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., and Tip Biosystems.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Protein Purification & Isolation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Purification & Isolation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Purification & Isolation Market?
4. What is the competitive strategic window for opportunities in the Global Protein Purification & Isolation Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Purification & Isolation Market?
6. What is the market share of the leading vendors in the Global Protein Purification & Isolation Market?
7. What modes and strategic moves are considered suitable for entering the Global Protein Purification & Isolation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for more accurate and rapid purification kits
5.1.1.2. Increasing government investment in pharmaceutical and biotechnological R&D
5.1.1.3. Rising adoption for automated protein purification instruments
5.1.2. Restraints
5.1.2.1. High cost associated with purification instrument and lack of skilled professionals
5.1.3. Opportunities
5.1.3.1. Significant opportunities in untapped emerging markets
5.1.3.2. Increasing demand from protein-therapeutics
5.1.4. Challenges
5.1.4.1. Development of a high-throughput pipeline for membrane protein expression and purification
5.2. Cumulative Impact of COVID-19
6. Protein Purification & Isolation Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Columns
6.3.2. Kits
6.3.3. Magnetic beads
6.3.4. Reagents
6.3.5. Resins
6.3. Instruments
7. Protein Purification & Isolation Market, by Technology
7.1. Introduction
7.2. Chromatography
7.3.1. Affinity chromatography
7.3.2. Hydrophobic interaction chromatography
7.3.3. Ion exchange chromatography
7.3.4. Reversed phase chromatography
7.3.5. Size exclusion chromatography
7.3. Electrophoresis
7.4.1. Capillary electrophoresis
7.4.2. Gel electrophoresis
7.4.3. Isoelectric focusing
7.4. Precipitation
7.5. Ultrafiltration
7.6. Western blotting
8. Protein Purification & Isolation Market, by Application
8.1. Introduction
8.2. Biomarker discovery
8.3. Diagnostics
8.4. Drug screening
8.5. Protein-protein interaction studies
9. Protein Purification & Isolation Market, by End-user
9.1. Introduction
9.2. Academic and research institutes
9.3. CROs
9.4. Hospitals
9.5. Pharmaceutical and biotechnological companies
10. Americas Protein Purification & Isolation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Protein Purification & Isolation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Protein Purification & Isolation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abcam PLC
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Agilent Technologies
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BioAstrum Corporation
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. BioVision, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Creative Biostructure
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Eurofins DiscoverX Products
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Expedeon Ltd.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. GEA Group Aktiengesellschaft
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. General Electric Company
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Geno Technology Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Jiangsu kaimi membrane technology Co.,Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Labome
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Merck KGaA
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Norgen Biotek Corp.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. OPRL Biosciences Pvt.,Ltd.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Promega Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Purolite
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Qiagen N.V
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Roche Applied Science
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Sigma-Aldrich Co.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Synder Filtration, Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Takara Bio Inc.
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Thermo Fisher Scientific Inc.
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Tip Biosystems
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing